Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta
- 24 May 2005
- journal article
- Published by Elsevier in Toxicology
- Vol. 211 (3) , 242-252
- https://doi.org/10.1016/j.tox.2005.03.011
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The Involvement of the Pregnane X Receptor in Hepatic Gene Regulation during Inflammation in MiceThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Importance of P-glycoprotein at blood–tissue barriersTrends in Pharmacological Sciences, 2004
- SUPPRESSION OF DRUG-METABOLIZING ENZYMES AND EFFLUX TRANSPORTERS IN THE INTESTINE OF ENDOTOXIN-TREATED RATSDrug Metabolism and Disposition, 2004
- Lipopolysaccharide and Cecal Ligation/Puncture Differentially Affect the Subcellular Distribution of the Pregnane X Receptor but Consistently Cause Suppression of Its Target Genes CYP3AShock, 2003
- Exacerbation of Alcoholic Liver Injury by Enteral Endotoxin in RatsHepatology, 2000
- Expression of Thioredoxin and Thioredoxin Reductase in Placentae of Pregnant Mice Exposed to LipopolysaccharidePlacenta, 1999
- The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.Journal of Clinical Investigation, 1998
- IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3AAnnual Review of Pharmacology and Toxicology, 1998
- Regulation of Cytochromes P450 During Inflammation and InfectionDrug Metabolism Reviews, 1997
- In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouseEuropean Journal of Immunology, 1990